Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

A Novel CRISPR/Cas9-Based Cellular Model to Explore Adenylyl Cyclase and cAMP Signaling.

Soto-Velasquez M, Hayes MP, Alpsoy A, Dykhuizen EC, Watts VJ.

Mol Pharmacol. 2018 Sep;94(3):963-972. doi: 10.1124/mol.118.111849. Epub 2018 Jun 27.

PMID:
29950405
2.

Autocrine Fibronectin Inhibits Breast Cancer Metastasis.

Shinde A, Libring S, Alpsoy A, Abdullah A, Schaber JA, Solorio L, Wendt MK.

Mol Cancer Res. 2018 Oct;16(10):1579-1589. doi: 10.1158/1541-7786.MCR-18-0151. Epub 2018 Jun 22.

PMID:
29934326
3.

Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.

Alpsoy A, Dykhuizen EC.

J Biol Chem. 2018 Mar 16;293(11):3892-3903. doi: 10.1074/jbc.RA117.001065. Epub 2018 Jan 26.

PMID:
29374058
4.

Protein kinase D2 silencing reduced motility of doxorubicin-resistant MCF7 cells.

Alpsoy A, Gündüz U.

Tumour Biol. 2015 Jun;36(6):4417-26. doi: 10.1007/s13277-015-3081-3. Epub 2015 Jan 21.

PMID:
25874490
5.

Etoposide resistance in MCF-7 breast cancer cell line is marked by multiple mechanisms.

Alpsoy A, Yasa S, Gündüz U.

Biomed Pharmacother. 2014 Apr;68(3):351-5. doi: 10.1016/j.biopha.2013.09.007. Epub 2014 Jan 28.

PMID:
24529846

Supplemental Content

Loading ...
Support Center